Skip to main content
Top
Published in: Journal of Artificial Organs 3/2020

01-09-2020 | Bronchoscopy | Case Report

Acquired factor XIII deficiency in two patients with bleeding events during veno-venous extracorporeal membrane oxygenation treatment

Authors: Asami Ito, Yoshiaki Iwashita, Ryo Esumi, Ken Sasaki, Masahiro Yukimitsu, Takafumi Kato, Eiji Kawamoto, Kei Suzuki, Hiroshi Imai

Published in: Journal of Artificial Organs | Issue 3/2020

Login to get access

Abstract

We report two cases of acquired factor XIII deficiency with bleeding events during veno-venous extracorporeal membrane oxygenation (ECMO). Case 1: A 76-year-old man diagnosed with aspiration pneumonia after near-drowning was started on ECMO. Later, the patient presented with hemoptysis and anemia. Blood tests showed a decreased factor XIII activity of 29%. Although the patient recovered after receiving 1200 International Units of factor XIII concentrate, the patient had another episode of decreased factor XIII activity and bloody stool and was treated again with factor XIII concentrate. Case 2: A 48-year-old female diagnosed with pneumonia was started on ECMO. Soon after, she presented with hemoptysis and anemia. Blood tests showed a decreased factor XIII activity of 39%. The patient was treated with 720 IU of factor XIII concentrate with good recovery. Acquired factor XIII deficiency cannot be detected by routine coagulation tests, therefore it may be under-diagnosed in the ICU. Detection of acquired factor XIII deficiency is essential when treating a bleeding ECMO patient.
Literature
1.
go back to reference Mazzeffi M, Greenwood J, Tanaka K, et al. Bleeding, transfusion, and mortality on extracorporeal life support: ECLS working group on thrombosis and hemostasis. Ann Thorac Surg. 2016;101:682–9.CrossRef Mazzeffi M, Greenwood J, Tanaka K, et al. Bleeding, transfusion, and mortality on extracorporeal life support: ECLS working group on thrombosis and hemostasis. Ann Thorac Surg. 2016;101:682–9.CrossRef
2.
go back to reference Aubron C, DePuydt J, Belon F, et al. Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation. Ann Intensive Care. 2016;6:97.CrossRef Aubron C, DePuydt J, Belon F, et al. Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation. Ann Intensive Care. 2016;6:97.CrossRef
3.
go back to reference Malfertheiner MV, Pimenta LP, Bahr VV, et al. Acquired von Willebrand syndrome in respiratory extracorporeal life support; a systematic review of the literature. Crit Care Resusc. 2017;19:45–52.PubMed Malfertheiner MV, Pimenta LP, Bahr VV, et al. Acquired von Willebrand syndrome in respiratory extracorporeal life support; a systematic review of the literature. Crit Care Resusc. 2017;19:45–52.PubMed
5.
go back to reference Heilmann C, Geisen U, Beyersdorf F, et al. Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). Intensive Care Med. 2012;38:62–8.CrossRef Heilmann C, Geisen U, Beyersdorf F, et al. Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). Intensive Care Med. 2012;38:62–8.CrossRef
6.
go back to reference Gerlach R, Raabe A, Zimmermann M, et al. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol. 2000;54:260–6.CrossRef Gerlach R, Raabe A, Zimmermann M, et al. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol. 2000;54:260–6.CrossRef
7.
go back to reference Ternström L, Radulovic V, Karlsson M, et al. Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: A prospective observational study. Thromb Res. 2010;126:128–33.CrossRef Ternström L, Radulovic V, Karlsson M, et al. Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: A prospective observational study. Thromb Res. 2010;126:128–33.CrossRef
8.
go back to reference Kalbhenn J, Wittau N, Schmutz A, et al. Identification of acquired coagulation disorders and effects of target-controlled coagulation factorsubstitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy. Perfusion. 2015;30:675–82.CrossRef Kalbhenn J, Wittau N, Schmutz A, et al. Identification of acquired coagulation disorders and effects of target-controlled coagulation factorsubstitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy. Perfusion. 2015;30:675–82.CrossRef
9.
go back to reference Triulzi DJ. Blood transfusion therapy: a physician's handbook. 7th ed. American Association of Blood Banks; 2002. p. 27. Triulzi DJ. Blood transfusion therapy: a physician's handbook. 7th ed. American Association of Blood Banks; 2002. p. 27.
Metadata
Title
Acquired factor XIII deficiency in two patients with bleeding events during veno-venous extracorporeal membrane oxygenation treatment
Authors
Asami Ito
Yoshiaki Iwashita
Ryo Esumi
Ken Sasaki
Masahiro Yukimitsu
Takafumi Kato
Eiji Kawamoto
Kei Suzuki
Hiroshi Imai
Publication date
01-09-2020
Publisher
Springer Japan
Published in
Journal of Artificial Organs / Issue 3/2020
Print ISSN: 1434-7229
Electronic ISSN: 1619-0904
DOI
https://doi.org/10.1007/s10047-019-01148-w

Other articles of this Issue 3/2020

Journal of Artificial Organs 3/2020 Go to the issue